Healthcare -
Biotechnology - NASDAQ - US
$ 11.17
-1.97 %
$ 552 M
Market Cap
-3.04
P/E
KALV - OTHER CURRENT LIABILITIES
Other Current Liabilities KALV - KalVista Pharmaceuticals, Inc.
12.4 M
LAST VALUE
33.46%
2 YEAR CAGR
17.26%
5 YEAR CAGR
41.11%
10 YEAR CAGR